These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 32608097)

  • 1. Comparison of In Vitro Inactivation of SARS CoV-2 with Hydrogen Peroxide and Povidone-Iodine Oral Antiseptic Rinses.
    Bidra AS; Pelletier JS; Westover JB; Frank S; Brown SM; Tessema B
    J Prosthodont; 2020 Aug; 29(7):599-603. PubMed ID: 32608097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid In-Vitro Inactivation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Using Povidone-Iodine Oral Antiseptic Rinse.
    Bidra AS; Pelletier JS; Westover JB; Frank S; Brown SM; Tessema B
    J Prosthodont; 2020 Jul; 29(6):529-533. PubMed ID: 32511851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vitro Efficacy of a Povidone-Iodine Nasal Antiseptic for Rapid Inactivation of SARS-CoV-2.
    Frank S; Brown SM; Capriotti JA; Westover JB; Pelletier JS; Tessema B
    JAMA Otolaryngol Head Neck Surg; 2020 Nov; 146(11):1054-1058. PubMed ID: 32940656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of Povidone-Iodine Nasal and Oral Antiseptic Preparations Against Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2).
    Pelletier JS; Tessema B; Frank S; Westover JB; Brown SM; Capriotti JA
    Ear Nose Throat J; 2021 Apr; 100(2_suppl):192S-196S. PubMed ID: 32951446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Povidone-Iodine Use in Sinonasal and Oral Cavities: A Review of Safety in the COVID-19 Era.
    Frank S; Capriotti J; Brown SM; Tessema B
    Ear Nose Throat J; 2020 Nov; 99(9):586-593. PubMed ID: 32520599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro inactivation of SARS-CoV-2 using a povidone-iodine oral rinse.
    Shet M; Westover J; Hong R; Igo D; Cataldo M; Bhaskar S
    BMC Oral Health; 2022 Feb; 22(1):47. PubMed ID: 35216566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repurposing 0.5% povidone iodine solution in otorhinolaryngology practice in Covid 19 pandemic.
    Khan MM; Parab SR; Paranjape M
    Am J Otolaryngol; 2020; 41(5):102618. PubMed ID: 32574894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Considerations for povidone-iodine antisepsis in pediatric nasal and pharyngeal surgery during the COVID-19 pandemic.
    Chorney SR; Rizzi MD; Dedhia K
    Am J Otolaryngol; 2020; 41(6):102737. PubMed ID: 32979667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of mouthwashes against COVID-19 in dentistry.
    Vergara-Buenaventura A; Castro-Ruiz C
    Br J Oral Maxillofac Surg; 2020 Oct; 58(8):924-927. PubMed ID: 32859459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of "Essential Iodine Drops" against Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2).
    Köntös Z
    PLoS One; 2021; 16(7):e0254341. PubMed ID: 34242340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mouth rinses efficacy on salivary SARS-CoV-2 viral load: A randomized clinical trial.
    Alzahrani MM; Bamashmous S; Alkharobi H; Alghamdi A; Alharbi RH; Hassan AM; Darwish M; Bukhari A; Mahmoud AB; Alfaleh MA; Mirza AA; Abuzenadah AM; Abujamel TS; Hashem AM
    J Med Virol; 2023 Jan; 95(1):e28412. PubMed ID: 36527332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential Effects of Antiseptic Mouth Rinses on SARS-CoV-2 Infectivity In Vitro.
    Xu C; Wang A; Hoskin ER; Cugini C; Markowitz K; Chang TL; Fine DH
    Pathogens; 2021 Mar; 10(3):. PubMed ID: 33804294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A quadruple blind, randomised controlled trial of gargling agents in reducing intraoral viral load among hospitalised COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial.
    Khan FR; Kazmi SMR; Iqbal NT; Iqbal J; Ali ST; Abbas SA
    Trials; 2020 Sep; 21(1):785. PubMed ID: 32928313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of mouth rinses with povidone-iodine and hydrogen peroxide in patients with COVID-19.
    Pablo-Marcos D; Abascal B; Lloret L; Gutiérrez Cuadra M; Velasco N; Valero C
    Enferm Infecc Microbiol Clin (Engl Ed); 2023 Mar; 41(3):173-175. PubMed ID: 36058840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virucidal effect of povidone-iodine against SARS-CoV-2
    Wang Y; Wu Y; Wang Q; Zhu J; Shi W; Han Z; Zhang Y; Chen K
    J Int Med Res; 2021 Dec; 49(12):3000605211063695. PubMed ID: 34914884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Povidone-iodine solution as SARS-CoV-2 prophylaxis for procedures of the upper aerodigestive tract a theoretical framework.
    Naqvi SHS; Citardi MJ; Cattano D; Ostrosky-Zeichner L; Knackstedt MI; Karni RJ
    J Otolaryngol Head Neck Surg; 2020 Oct; 49(1):77. PubMed ID: 33109269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Review of Topical Povidone-iodine to Decrease Viral Load of COViD-19.
    Benson KM; Mancini AA; Brodeur MR
    Sr Care Pharm; 2021 May; 36(5):238-241. PubMed ID: 33879284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral effect of multipurpose contact lens disinfecting solutions against coronavirus.
    Yasir M; Kumar Vijay A; Willcox M
    Cont Lens Anterior Eye; 2022 Oct; 45(5):101513. PubMed ID: 34465537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of antiseptic mouthrinses against SARS-CoV-2: A prospective randomized placebo-controlled pilot study.
    Fantozzi PJ; Pampena E; Pierangeli A; Oliveto G; Sorrentino L; Di Vanna D; Pampena R; Lazzaro A; Gentilini E; Mastroianni CM; D'Ettorre G; Polimeni A; Romeo U; Villa A
    Am J Otolaryngol; 2022; 43(6):103549. PubMed ID: 35988522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 Viral Inactivation Using Low Dose Povidone-Iodine Oral Rinse-Immediate Application for the Prosthodontic Practice.
    Tessema B; Frank S; Bidra A
    J Prosthodont; 2020 Jul; 29(6):459. PubMed ID: 32542782
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 24.